• Home
  • NEW DAY MEDICINE
  • 1 (75) 2025
  • 20 -1 (75) 2025 - Tosheva H.B., Khotamova R.S. - KIDNEY HEMODYNAMICS IN CHRONIC HEART FAILURE DEVELOPED ON THE BASIS OF RHEUMATIC DEFECTS

20 -1 (75) 2025 - Tosheva H.B., Khotamova R.S. - KIDNEY HEMODYNAMICS IN CHRONIC HEART FAILURE DEVELOPED ON THE BASIS OF RHEUMATIC DEFECTS

KIDNEY HEMODYNAMICS IN CHRONIC HEART FAILURE DEVELOPED ON THE BASIS OF RHEUMATIC DEFECTS

Tosheva H.B. - Bukhara State Medical Institute named after Abu Ali ibn Sina

Khotamova R.S. - Tashkent Medical Academy

Gadaeva N.A. - Tashkent Medical Academy

Resume

In chronic heart failure developed on the basis of rheumatic heart defects, inflammatory processes are long and hidden. The article compares renal hemodynamics before and after treatment in patients with chronic heart failure developed on the basis of rheumatic heart defects and ischemic heart disease. The analysis showed that resistance index is high in rheumatic heart defects. After the standard treatment with addition of sodium glucose cotransporter type 2 inhibitors in patients, the decrease of resistance index led to positive changes in kidney function. Correlations between the resistance index and a number of kidney markers were also studied.

Key words: rheumatic defects, chronic heart failure, kidney hemodynamics.

First page

96

Last page

106

For citation:Tosheva H.B., Khotamova R.S., Gadaeva N.A. - KIDNEY HEMODYNAMICS IN CHRONIC HEART FAILURE DEVELOPED ON THE BASIS OF RHEUMATIC DEFECTS//New Day in Medicine 1(75)2025 96-106 https://https://newdayworldmedicine.com/en/new_day_medicine/1-75-2025

List of References

  1. Bongartz L.G., Braam B., Gaillard C.A. et al. Target organ cross talk in cardiorenal syndrome: animal models. //Am J Physiol Renal Physiol. 2012;303(9):1253-63.
  2. Cowie M.R., Komajda M., Murray-Thomas T. et al. Prevalence and impact of worsening renal function in patients hospitalized with decompensated heart failure: results of the prospective outcomes study in heart failure (POSH). //Eur Heart J. 2006;27(10):1216-22. 3-37.
  3. Damman K., Navis G., Voors A.A. et al. Worsening renal function and prognosis in heart failure: systematic review and meta-analysis. //J Card Fail. 2007;13(8):599-608.
  4. Damman, K.; Valente, M.A.; Voors, A.A.; O’Connor, C.M.; Van Veldhuisen, D.J.; Hillege, H.L. Renal impairment, worsening renal function, and outcome in patients with heart failure: An updated meta-analysis. //Eur. Heart J. 2014;35:455-469. [Google Scholar] [CrossRef].
  5. Forman D.E., Butler J., Wang Y. et al. Incidence, predictors at admission, and impact of worsening renal function among patients hospitalized with heart failure. //J Am Coll Cardiol. 2004;43(1):61-7.
  6. Gottlieb S.S., Abraham W., Butler J. et al. The prognostic importance of different definitions of worsening renal function in congestive heart failure. //J Card Fail. 2002;8(3):136-41.
  7. Hatamizadeh P., Fonarow G.C., Budoff M.J. et al. Cardiorenal syndrome: pathophysiology and potential targets for clinical management. //Nat Rev Nephrol. 2013;9(2):99-111
  8. Kottgen, A.; Russell, S.D.; Loehr, L.; Crainiceanu, C.M.; Rosamond, W.D.; Chang, P.P.; Chambless, L.E.; Coresh, J. Reduced kidney function as a risk factor for incident heart failure: The atherosclerosis risk in communities (ARIC) study. //J. Am. Soc. Nephrol. 2007;18:1307-1315. [Google Scholar] [CrossRef].
  9. Krumholz H.M., Chen Y.T., Vaccarino V. et al. Correlates and impact on outcomes of worsening renal function in patients > or =65 years of age with heart failure. //Am J Cardiol. 2000;85(9):1110-3.
  10. McAlister, F.A.; Ezekowitz, J.; Tarantini, L.; Squire, I.; Komajda, M.; Bayes-Genis, A.; Gotsman, I.; Whalley, G.; Earle, N.; Poppe, K.K.; et al. Renal dysfunction in patients with heart failure with preserved versus reduced ejection fraction: Impact of the new Chronic Kidney Disease-Epidemiology Collaboration Group formula. //Circ. Heart Fail. 2012;5:309-314. [Google Scholar] [CrossRef].
  11. Pokhrel N., Maharjan, N., Dhakal, B. et al., Cardiorenal syndrome: A literature review. //Exp Clin Cardiol, 2008;13(4):165-70.
  12. Rea M.E.; Dunlap, M.E. Renal hemodynamics in heart failure: Implications for treatment. //Curr. Opin. Nephrol. Hypertens. 2008;17:87-92. [Google Scholar] [CrossRef].
  13. Struthers A.D.; MacDonald, T.M. Review of aldosterone- and angiotensin II-induced target organ damage and prevention. //Cardiovasc. Res. 2004;61:663-670. [Google Scholar] [CrossRef][Green Version].
  14. Torres V.E. Vasopressin in chronic kidney disease: An elephant in the room? //Kidney Int. 2009;76:925-928. [Google Scholar] [CrossRef].
  15. Карпов Ю.А., Гендлин Г.Е., Эффективность блокаторов рецепторов ангиотензина на разных этапах сердечно сосудистого континуума — фокус на валсартан. //Атмосфера. Новости кардиологии 2012;2:27-31.
  16. Медведева Е.А., Шиляева Н.В. и др. Кардиоренальный синдром при хронической сердечной недостаточности: патогенез, диагностика, прогноз и возможности терапии. //Российский кардиологический журнал. 2017;141(1):136-141.
  17. Резник Е.В. Почки как орган-мишень при хронической сердечной недостаточности. //Lamber. 2011; 188 с.
  18. Резник Е.В., Гендлин Г.Е., Хрипун А.И. и др. Функциональное состояние почек, экскреция альбумина с мочой и почечная гемодинамика у больных с хронической сердечной недостаточностью. //Нефрология и диализ. 2010;12(4):275-286.
  19. Сторожаков Г.И., Гендлин Г.Е., Резник Е.В., Болеет сердце — страдают почки: кардиоренальный синдром при хронической сердечной недостаточности. //Лечебное дело. 2009;1:27-36.
  20. Шутов А.М., Машина Т.В., Мардер Н.Я., Хроническая сердечная недостаточность у больных с хронической болезнью почек. //Нефрология и диализ. 2005;7(2):140-144.

    file

    download